FinTrust Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.17M	Sell	1,950 -34	-2%	-$37.8K	0.37%	57
2024 Q2	$2.09M	Sell	1,984 -39	-2%	-$37.8K	0.38%	55
2024 Q1	$1.95M	Sell	2,023 -63	-3%	-$59.9K	0.38%	55
2023 Q4	$1.83M	Buy	2,086 +149	+8%	+$123K	0.37%	55
2023 Q3	$1.59M	Sell	1,937 -82	-4%	-$64.4K	0.35%	58
2023 Q2	$1.45M	Buy	2,019 +250	+14%	+$193K	0.35%	72
2023 Q1	$1.33M	Hold	1,769	–	–	0.32%	75
2022 Q4	$1.28M	Sell	1,769 -72	-4%	-$53.1K	0.31%	78
2022 Q3	$1.31M	Buy	1,841 +48	+3%	+$30.2K	0.34%	72
2022 Q2	$1.05M	Sell	1,793 -218	-11%	-$142K	0.26%	89
2022 Q1	$1.41M	Buy	2,011 +1,393	+225%	+$881K	0.33%	72
2021 Q4	$389K	Sell	618 -481	-44%	-$296K	0.09%	193
2021 Q3	$665K	Buy	1,099 +824	+300%	+$512K	0.18%	116
2021 Q2	$154K	Buy	275 +38	+16%	+$19.3K	0.04%	330
2021 Q1	$112K	Buy	237 +162	+216%	+$78.9K	0.03%	388
2020 Q4	$36K	Buy	+75	New	+$40.5K	0.01%	547
2019 Q2	–	Sell	-32	Closed	-$13K	–	1222
2019 Q1	$13K	Hold	32	–	–	0.01%	712
2018 Q4	$12K	Buy	+32	New	+$11.7K	0.01%	732